Yahoo Web Search

Search results

    • Q1 2024 Karyopharm Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 5 days ago

      Given the limited efficacy achieved with...53 wild-type subgroup of the CMV trial, which evaluated selinexor as a maintenance therapy, has generated substantial enthusiasm from the ...

    • Q1 2024 Agenus Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

      I will now turn the call to Dr. Steven O'Day, our Chief Medical Officer, will provide an update on the latest developments in our buyback program. Stephen will focus, particularly ...

    • Q1 2024 Nektar Therapeutics Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 4 days ago

      We believe REZPEG has the potential to be a significant advancement in the treatment of atopic dermatitis. The new and...currently available therapies are not durable, have high relapse rates ...

    • Q1 2024 X4 Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

      We continue to validate our current estimates and through our growing number of conversations with physicians in the field and at medical conferences, we remain very confident ...

    • Scout Wins Second Consecutive MedTech Breakthrough Award

      FOX21 Colorado Springs· 5 days ago

      Scout, a premier provider of clinical trial services, announced its Scout Portal platform has clinched the "Best Patient Portal" award for the second consecutive year at the 8th annual MedTech ...